Aberrant activation of HGF/MET signaling as a therapeutic target in AML

Yves Pommier

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

Leukaemia

Harlan S. Robins

Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leukemia

Leukaemia

Alan B. Cantor

Regulation of RUNX1 Multiprotein Complex Formation during Hematopoiesis

Leukaemia

Hematology and hematologic malignancies

Tait D Shanafelt

Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Ross L Levine

Role of TET2 mutations in malignant transformation and acute myeloid leukemia

Leukaemia

Thomas Waldmann

IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

Leukaemia

Pathology Hematology and hematologic malignancies

Soheil Meshinchi

Biology and Prognostic Implications of FLT3 Mutations in AML

Leukaemia

Terry Fry

Adoptive T cell Therapy for Pediatric Leukemia

Leukaemia

Pediatric oncology or childhood cancer

Ulrich G. Steidl

Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia

Leukaemia